Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Maria Cirillo

Showing results (31-40 of 189) with videos related to

Pageof 19
Sort By:
Gut Pathogens|January 17, 2025
Whole-genome sequencing-based characterization of Salmonella enterica Serovar Enteritidis and Kentucky isolated from laying hens in northwest of Iran, 2022-2023Shirin Vakili, Mehri Haeili, Adel Feizi, et al.
Folia Medica|August 31, 2022
Whole genome sequencing of Bulgarian rifampicin resistant <i>Mycobacterium tuberculosis</i> strainsStanislava Yordanova, Elizabeta Bachiyska, Elisa Tagliani, et al.
The European Respiratory Journal|April 20, 2021
Tests for tuberculosis infection: landscape analysisYohhei Hamada, Daniela Maria Cirillo, Alberto Matteelli, et al.
Frontiers in Microbiology|February 23, 2023
Advantages of long- and short-reads sequencing for the hybrid investigation of the <i>Mycobacterium tuberculosis</i> genomeFederico Di Marco, Andrea Spitaleri, Simone Battaglia, et al.
The European Respiratory Journal|February 4, 2017
Moving towards tuberculosis elimination: a call for action from Italy and a possible model for other low tuberculosis incidence countriesFrancesco Blasi, Alberto Matteelli, Giovanni Sotgiu, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2019
Isoniazid Resistance in <i>Mycobacterium tuberculosis</i> Is a Heterogeneous Phenotype Composed of Overlapping MIC Distributions with Different Underlying Resistance MechanismsArash Ghodousi, Elisa Tagliani, Eranga Karunaratne, et al.
Breathe (Sheffield, England)|July 26, 2023
Rolling out new anti-tuberculosis drugs without diagnostic capacityTara Ness, Le Hong Van, Ilze Petermane, et al.
The European Respiratory Journal|October 20, 2022
The aminoglycoside-modifying enzyme Eis2 represents a new potential <i>in vivo</i> target for reducing antimicrobial drug resistance in <i>Mycobacterium abscessus</i> complexNicola Ivan Lorè, Fabio Saliu, Andrea Spitaleri, et al.
The European Respiratory Journal|April 4, 2020
Celebrating World Tuberculosis Day at the time of COVID-19Riccardo Alagna, Giorgio Besozzi, Luigi Ruffo Codecasa, et al.
Microbiology Spectrum|June 1, 2026
Genomic characterization of the emerging multidrug-resistant <i>Klebsiella pneumoniae</i> ST6668 clone in northern Italy, 2020-2025Maryam Omrani, Virginia Batignani, Kiarash Moghaddasi, et al.
Pageof 19

Showing results (31-40 of 189) with videos related to

Sort By:
Pageof 19
Gut Pathogens|January 17, 2025
Whole-genome sequencing-based characterization of Salmonella enterica Serovar Enteritidis and Kentucky isolated from laying hens in northwest of Iran, 2022-2023Shirin Vakili, Mehri Haeili, Adel Feizi, et al.
Folia Medica|August 31, 2022
Whole genome sequencing of Bulgarian rifampicin resistant <i>Mycobacterium tuberculosis</i> strainsStanislava Yordanova, Elizabeta Bachiyska, Elisa Tagliani, et al.
The European Respiratory Journal|April 20, 2021
Tests for tuberculosis infection: landscape analysisYohhei Hamada, Daniela Maria Cirillo, Alberto Matteelli, et al.
Frontiers in Microbiology|February 23, 2023
Advantages of long- and short-reads sequencing for the hybrid investigation of the <i>Mycobacterium tuberculosis</i> genomeFederico Di Marco, Andrea Spitaleri, Simone Battaglia, et al.
The European Respiratory Journal|February 4, 2017
Moving towards tuberculosis elimination: a call for action from Italy and a possible model for other low tuberculosis incidence countriesFrancesco Blasi, Alberto Matteelli, Giovanni Sotgiu, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2019
Isoniazid Resistance in <i>Mycobacterium tuberculosis</i> Is a Heterogeneous Phenotype Composed of Overlapping MIC Distributions with Different Underlying Resistance MechanismsArash Ghodousi, Elisa Tagliani, Eranga Karunaratne, et al.
Breathe (Sheffield, England)|July 26, 2023
Rolling out new anti-tuberculosis drugs without diagnostic capacityTara Ness, Le Hong Van, Ilze Petermane, et al.
The European Respiratory Journal|October 20, 2022
The aminoglycoside-modifying enzyme Eis2 represents a new potential <i>in vivo</i> target for reducing antimicrobial drug resistance in <i>Mycobacterium abscessus</i> complexNicola Ivan Lorè, Fabio Saliu, Andrea Spitaleri, et al.
The European Respiratory Journal|April 4, 2020
Celebrating World Tuberculosis Day at the time of COVID-19Riccardo Alagna, Giorgio Besozzi, Luigi Ruffo Codecasa, et al.
Microbiology Spectrum|June 1, 2026
Genomic characterization of the emerging multidrug-resistant <i>Klebsiella pneumoniae</i> ST6668 clone in northern Italy, 2020-2025Maryam Omrani, Virginia Batignani, Kiarash Moghaddasi, et al.
Pageof 19